MedPath

IDROP, INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

Phase 2
Completed
Conditions
Cataract in Inflammatory Ocular Disorders
Interventions
Drug: Placebo Dose 1
Drug: Placebo Dose 2
First Posted Date
2021-01-15
Last Posted Date
2021-01-15
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT04711213
Locations
πŸ‡ΈπŸ‡»

Centre De. Oftalmologia, San Salvador, El Salvador

A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery

Phase 1
Completed
Conditions
Inflammation Eye
Interventions
First Posted Date
2018-09-27
Last Posted Date
2019-05-24
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT03687931
Locations
πŸ‡ΊπŸ‡Έ

Arizona Eye Center, Chandler, Arizona, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.